Clinical Expert Commentaries

Clinical Expert Commentaries published on November 24, 2009 in VTE Risk Reduction
Dr. Anderson discusses the risk factors for thromboembolism in multiple myeloma patients, as well as methods for managing this risk.
Clinical Expert Commentaries published on October 21, 2009 in Stem Cell Transplant
Dr. Mohrbacher discusses the indication for and positioning of stem cell transplantation in the treatment of multiple myeloma.
Clinical Expert Commentaries published on August 24, 2009 in Test/Monitoring
Dr. Berenson discusses multiple clinical tests to evaluate myeloma patient treatment response and key considerations to avoid missing disease progression.
Clinical Expert Commentaries published on July 10, 2009 in Stem Cell Transplant
Dr. Bensinger discusses criteria and prognostic determinants in assessing patient eligibility for stem cell transplantation.
Clinical Expert Commentaries published on May 29, 2009 in Risk Assessment
Dr. Anderson discusses risk stratification in the age of novel agents for myeloma
Clinical Expert Commentaries published on May 29, 2009 in Stem Cell Transplant
Dr. Giralt describes the role, timing, and evidence for transplant in multiple myeloma
Clinical Expert Commentaries published on April 20, 2009 in VTE Risk Reduction
Dr. Mohrbacher discusses appropriate anticoagulation for multiple myeloma patients treated with combination therapies that are associated with increased risk of thromboembolic complications.
Clinical Expert Commentaries published on March 18, 2009 in PN Risk Reduction
Dr. Richardson summarizes the latest information on the prevention and management of peripheral neuropathy in patients with multiple myeloma.
Tiffany Richards summarizes some of the challenges that community nurses face and discusses best practices in handling those challenges.
Page 3 of 4
Results 21 - 30 of 32